The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / ACR Board of Directors Advocates for Rheumatology on Capitol Hill

ACR Board of Directors Advocates for Rheumatology on Capitol Hill

May 1, 2013 • By Staff

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Get Involved in Advocacy

The ACR Board of Directors will converge on Washington, D.C., this month to meet with members of Congress and advocate on behalf of ACR members. They will carry three critical messages to Capitol Hill: access to rheumatology, access to treatments, and funding for research.

You Might Also Like
  • The ACR’s Advocates for Arthritis 2016 Legislative Fly-In Heads to Capitol Hill
  • ACR Leaders Converge on Capitol Hill
  • Participate in Virtual Capitol Hill Meetings with the ACR
Explore This Issue
May 2013
Also By This Author
  • Five Most Important Fraud, Abuse Laws Applicable to Physicians

Access to Rheumatology

The ACR is urging members of Congress to support the bipartisan efforts of the House Energy and Commerce and Ways and Means committees to overhaul the defective Sustainable Growth Rate (SGR) payment formula. The ACR continues to work with the staff and leadership of these committees as they craft their plan to replace the SGR with a more viable physician-payment system. It is critical that the new system has multiple options and recognizes the specialized care rheumatologists provide. The ACR is also carrying the message that cuts to physician reimbursements, including the 2% sequester cut to Medicare, have seriously detrimental effects on rheumatologists’ ability to see Medicare patients and operate practices. The sequester cuts must be reversed.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Access to Treatments

The ACR is asking members of Congress to cosponsor H.R. 460, the Patients’ Access to Treatments Act of 2013. This bipartisan legislation, which has been championed by the ACR and other members of the Coalition for Accessible Treatments, enables patient access to critical treatments by limiting cost sharing for medications in a specialty-drug tier to the dollar amount a plan requires for drugs in its highest nonpreferred brand–drug tier. The bill currently has 29 Democratic and 11 Republican cosponsors. The ACR serves as co-chair of the 20-member Coalition for Accessible Treatments.

Funding for Research

When the federal government’s sequestration cuts were enacted earlier this year, funding for the National Institutes of Health (NIH) was cut by more than 5%. The ACR is very concerned about the implication of these cuts for medical innovation, particularly the potential effect on new treatments for arthritis and rheumatic diseases. It is important that Congress understands the impact of these cuts and increases funding to improve lives, create jobs, and decrease healthcare costs.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Think Nationally, Advocate Locally

You can help ensure the future of rheumatology and your patients’ continued access to quality care by sharing your thoughts on the above priorities with your legislators. Members of Congress have regular district work periods when they are available to meet with constituents in their local offices. This is an important opportunity to educate legislators and build relationships. Take the step of scheduling a meeting during an upcoming district work period: May 27–31, July 1–5, or August 5–September 6. If you would like assistance scheduling or preparing for a meeting—or if you would like to share photos and results from your visit—contact ACR staff at [email protected] or by calling (404) 633-3777.

Pages: 1 2 3 | Single Page

Filed Under: From the College, Legislation & Advocacy Tagged With: AC&R, Advocacy, Congress, rheumatologyIssue: May 2013

You Might Also Like:
  • The ACR’s Advocates for Arthritis 2016 Legislative Fly-In Heads to Capitol Hill
  • ACR Leaders Converge on Capitol Hill
  • Participate in Virtual Capitol Hill Meetings with the ACR
  • Rheumatology Professionals and Patient Advocates Take Their Stories to Capitol Hill

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)